Metabolic health Clinical Trials in Teaneck, NJ
As of June 2026, 1 paid clinical trial is recruiting for Metabolic health in Teaneck, New Jersey. Metabolic health research tests incretin therapies, dual and triple agonists, and lifestyle interventions for obesity, type 2 diabetes, insulin resistance, metabolic syndrome, and NAFLD/NASH. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for Metabolic health
·Clear filters·↓ Download CSVAbout research studies in Teaneck
Teaneck has approximately 45 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Teaneck
Researchers run research studies in Teaneck, NJ at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Holy Name Medical Center | Acute Myocardial Infarction (AMI), Advanced Non-Small Cell Lung Cancer, COVID-19 Infection | 12 |
| Holy Name Hospital | Melanoma, Bone Cancer, NOS, Breast Cancer | 9 |
| New Jersey Retina | Age-related Macular Degeneration (AMD), Diabetic Retinopathy, DR, Geographic Atrophy (GA) | 3 |
| Validated Claim Support | Hyperpigmentation, Skin Health | 2 |
| Dr. Patrick Perin | Perennial Allergic Rhinitis (PAR) | 1 |
| Fairleigh Dickinson University | Sexual Risk Behavior, Sexual and Reproductive Health, Substance Use Disorder (SUD) | 1 |
| Glaukos Investigative Site | Progressive Keratoconus | 1 |
| Holy Name | Solid Cancer | 1 |
| Holy Name Medical Center ( Site 3807) | Coronavirus Disease (COVID-19) | 1 |
| Holy Name Medical Center ( Site 6011) | Endometrial Cancer | 1 |
| Holy Name Medical Center /ID# 269340 | Folate Receptor-Alpha Positive, Recurrent Ovarian Cancer | 1 |
| Holy Name Medical Center /ID# 276240 | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant | 1 |
| Holy Name Medical Center /ID# 279017 | Fallopian Tube Cancer, Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer | 1 |
| Holy Name Medical Center- Site Number : 8400101 | Multiple Sclerosis | 1 |
| Local Institution - 0079 | Plaque Psoriasis | 1 |
| Local Institution - 0132 | Multiple Sclerosis, Relapsing-Remitting | 1 |
| NJRetina | Retinitis Pigmentosa | 1 |
| NJRetina Care Center - Teaneck | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| North Jersey Ortho Spclsts | Lumbar Spinal Stenosis | 1 |
| Retina Associates of NJ | Neovascular Age-Related Macular Degeneration | 1 |
| Retina Associates of New Jersey | Diabetic Macular Edema | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| Teaneck Surgery Center | Lumbar Spinal Stenosis | 1 |
| The Cornea & Laser Eye Institute | Presbyopia | 1 |
Active & Upcoming Studies in Teaneck (2026)
Recruiting trials in Teaneck grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (16 active studies)
- A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. · Phase 2 · AbbVie
- A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies · Phase 2 · AbbVie
Neurology & pain (4 active studies)
- Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis · Phase 3 · Sanofi
- Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. · Phase 3 · Novartis Pharmaceuticals
Eye & vision (4 active studies)
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Vaccines (2 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Mental health & behavior (1 active study)
- WORTH Paths Intervention · Fairleigh Dickinson University
Diabetes & metabolic (1 active study)
Cardiovascular (1 active study)
- Product Surveillance Registry · Medtronic
Common conditions studied in Teaneck
- Diabetic Macular Edema (2 active studies). Recruiting Diabetic Macular Edema studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Fallopian Tube Cancer (2 active studies). Recruiting Fallopian Tube Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Melanoma (2 active studies). Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease.
- Multiple Sclerosis (2 active studies). Multiple sclerosis trials test high-efficacy immunomodulators, remyelination therapies, and therapies aimed at progressive forms of the disease.
- Relapsing Multiple Sclerosis (2 active studies). Multiple sclerosis trials test high-efficacy immunomodulators, remyelination therapies, and therapies aimed at progressive forms of the disease.
- Retinitis Pigmentosa (2 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
Leading research sponsors in Teaneck
- AbbVie
- SWOG Cancer Research Network
- Bristol-Myers Squibb
- Hoffmann-La Roche
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Teaneck. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Teaneck
Hipa.ai aggregates every recruiting study in Teaneck from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Teaneck?
There are approximately 45 recruiting clinical trials in Teaneck, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Teaneck pay participants?
Most recruiting trials in Teaneck compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Teaneck?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Teaneck?
The most common conditions under active study in Teaneck include Diabetic Macular Edema (2), Fallopian Tube Cancer (2), Melanoma (2), Multiple Sclerosis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Teaneck?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Teaneck on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Teaneck?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Teaneck?
Recruiting research sites in Teaneck include Holy Name Medical Center, Holy Name Hospital, New Jersey Retina, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Teaneck right now?
The largest active categories in Teaneck are Cancer & tumors (16), Neurology & pain (4), Eye & vision (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.